# Monitoring the HePAtological TOXicity of Drugs (HePATOX)

> **NCT03833297** · — · COMPLETED · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 1000 (actual)

## Conditions studied

- Liver Diseases
- Liver Dysfunction
- Liver Failure
- Hepatotoxicity

## Interventions

- **DRUG:** Drugs inducing hepatological toxicity

## Key facts

- **NCT ID:** NCT03833297
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-04
- **Primary completion:** 2020-02-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833297, "Monitoring the HePAtological TOXicity of Drugs (HePATOX)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03833297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*